Stock TSHA TAYSHA GENE THERAPIES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Taysha Gene Therapies, Inc.

Equities

TSHA

US8776191061

Market Closed - Nasdaq
Other stock markets
 04:30:01 2024-05-03 pm EDT 		5-day change 1st Jan Change
2.57 USD -0.39% Intraday chart for Taysha Gene Therapies, Inc. +7.53% +45.20%
May. 02 Taysha Gene Therapies Announces Regenerative Medicine Advanced Therapy Designation Granted by U.S. FDA for TSHA-102 in Rett Syndrome CI
Apr. 09 Piper Sandler Initiates Taysha Gene Therapies at Overweight Rating With $9 Price Target MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
TAYSHA GENE THERAPIES, INC.
Other Biotechnology & Medical Research
-0.39%+7.53%+45.20%+280.80% - 483M
Bearish
Bullish
Neutral

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. TSHA Stock
  4. Charts Taysha Gene Therapies, Inc.
  5. Comparison Chart